ArriVent BioPharma, Inc. Common Stock (AVBP) — Defensive Interval Ratio
ArriVent BioPharma, Inc. Common Stock (AVBP) has a Defensive Interval Ratio of 3859 days as of March 2026. Defensive assets of $264.28 Million (cash $-, short-term investments $264.28 Million, receivables $-) cover 3859 days of daily cash needs of $68.48K/day. Check how tangible is ArriVent BioPharma, Inc. Common Stock's equity to evaluate the tangible quality of the company's equity base.
Defensive Interval Ratio
Defensive Assets
Daily Cash Need
Current Liabilities
ArriVent BioPharma, Inc. Common Stock Defensive Interval Ratio (2021–2025)
This chart shows how ArriVent BioPharma, Inc. Common Stock's Defensive Interval Ratio has evolved across 5 annual periods from 2021 to 2025. As of March 2026, the ratio stands at 3859 days, meaning defensive assets of $264.28 Million can fund 3859 days of operations without new revenue. Also explore AVBP net asset momentum to track the company's year-over-year net asset growth rate.
Annual Defensive Interval Ratio for ArriVent BioPharma, Inc. Common Stock (2021–2025)
The table below presents the year-by-year Defensive Interval Ratio for ArriVent BioPharma, Inc. Common Stock from 2021 to 2025, covering 5 annual filings. Each row shows defensive assets, daily cash need, the DIR in days, and the change in days compared to the prior year. For live market cap and the full company financial profile, see ArriVent BioPharma, Inc. Common Stock market cap and net worth.
| Year | DIR (days) | Defensive Assets (USD) | Daily Cash Need | Cash | ST Investments | Change (days) |
|---|---|---|---|---|---|---|
| 2025 | 3760 days | $267.28 Million | $71.08K/day | $- | $267.28 Million | ▲ +695 days |
| 2024 | 3065 days | $145.07 Million | $47.33K/day | $- | $144.57 Million | ▲ +3041 days |
| 2023 | 24 days | $761.00K | $31.85K/day | $- | $0.00 | ▲ +2 days |
| 2022 | 22 days | $500.00K | $22.90K/day | $- | $- | ▼ -28 days |
| 2021 | 50 days | $250.00K | $4.98K/day | $- | $- | — |